Transition to lanadelumab-flyo from three medications for a hereditary angioedema patient with a variant in the SYTL2 gene: A case report

被引：1

作者：

Burns, Stephanie ^{[1
]}

Lewis, Elena ^{[2
]}

机构：

[1] Western Michigan Univ, 1903 W Michigan Ave, Kalamazoo, MI 49008 USA

[2] Asthma Allergy Ctr, Portage, MI USA

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 04期

关键词：

hereditary angioedema; lanadelumab-flyo; SYTL2;

D O I：

10.1002/ccr3.4060

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-SERPING1 gene variant hereditary angioedema patients often need to take progesterone, attenuated androgens, and antifibrinolytics to control symptoms. These drugs may need to be tapered to extinction or reduced as lanadelumab-tlyo reaches maximum concentration.

引用

页码：2438 / 2441

页数：4

共 11 条

[1] The Effectiveness and Value of Lanadelumab and C1 Esterase Inhibitors for Prophylaxis of Hereditary Angioedema Attacks A Summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum [J].

Agboola, Foluso ;

Lubinga, Solomon ;

Carlson, Josh ;

Lin, Grace A. ;

Dreitlein, William B. ;

Pearson, Steven D. .

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (02) :143-148

[2] Transition to lanadelumab-flyo from three medications for a hereditary angioedema patient with a variant in the SYTL2 gene: A case report [J].

Burns, Stephanie ;

Lewis, Elena .

CLINICAL CASE REPORTS, 2021, 9 (04) :2438-2441

[3] US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema [J].

Busse, Paula J. ;

Christiansen, Sandra C. ;

Riedl, Marc A. ;

Banerji, Aleena ;

Bernstein, Jonathan A. ;

Castaldo, Anthony J. ;

Craig, Timothy ;

Davis-Lorton, Mark ;

Frank, Michael M. ;

Li, H. Henry ;

Lumry, William R. ;

Zuraw, Bruce L. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01) :132-150.e3

[4] Canadian physician survey on the medical management of hereditary angioedema [J].

Fu, Lisa ;

Kanani, Amin ;

Lacuesta, Gina ;

Waserman, Susan ;

Betschel, Stephen .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) :598-603

[5]

Hallstr?m BM., 2020, SYTL2 HUMAN PROTEIN

[6] Hereditary Angioedema with Normal C1 Inhibitor Update on Evaluation and Treatment [J].

Magerl, Markus ;

Germenis, Anastasios E. ;

Maas, Coen ;

Maurer, Marcus .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (03) :571-+

[7] Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics [J].

Marcelino-Rodriguez, Itahisa ;

Callero, Ariel ;

Mendoza-Alvarez, Alejandro ;

Perez-Rodriguez, Eva ;

Barrios-Recio, Javier ;

Garcia-Robaina, Jose C. ;

Flores, Carlos .

FRONTIERS IN GENETICS, 2019, 10

[8] Flow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency [J].

Nebenfuhrer, Zsuzsa ;

Szabo, Erika ;

Kajdacsi, Erika ;

Kohalmi, Kinga Viktoria ;

Karadi, Istvan ;

Zsary, Andras ;

Farkas, Henriette ;

Cervenak, Laszlo .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (01) :86-92

[9] Lanadelumab: First Global Approval [J].

Syed, Yahiya Y. .

DRUGS, 2018, 78 (15) :1633-1637

[10]

The GeneCards Suite Project Team, 2020, SYTL2 GEN GENECARDS

← 1 2 →